Former BlueBay Hedge Fund Manager Fined, Barred

Feb 3 2010 | 1:57pm ET

A former hedge fund manager has been barred by British regulators for falsifying his fund’s valuation.

Simon Treacher, who managed the US$1.2 billion Emerging Market Total Return Fund at BlueBay Asset Management, was also fined £140,000 for mismarking funds. According to the Financial Services Authority, Treacher cut-and-pasted bogus figures into seven broker quotes in 2007, inflating the fund’s valuation by some US$27 million. The altered valuations were then used to support Treacher’s mismarked positions, the FSA said.

The shenanigans cost BlueBay investors about US$650,000; the hedge fund, which was cleared of any wrongdoing by the regulator, has made those investors whole.

“His conduct, both in mismarking the funds and his dealings with us at the regulator, lacked integrity,” FSA enforcement chief Margaret Cole said. “Treacher’s actions undermined BlueBay’s independent valuation process and disadvantaged investors in the affected funds.”

Despite her harsh words for Treacher, the FSA cut his fine from £200,000 after he began cooperating with the regulator. Initially, the FSA said, Treacher offered “misleading answers” during its probe.

Treacher resigned from BlueBay in December 2008 after the London-based firm found he violated its internal valuation policy. The firm referred the case to the FSA, and said that its decision to close Treacher’s fund had nothing to do with his alleged malfeasance.


In Depth

Q&A: Sancus Capital And The Disruption Of The CLO Market

Oct 5 2017 | 6:28pm ET

Traditional collateralized loan obligation (CLO) funds in the U.S. market can offer...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Finding Success as Alternatives Converge

Oct 9 2017 | 4:00pm ET

Rising interest among institutional investors over the past several years has led...

 

From the current issue of